Literature DB >> 6493049

Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids.

O L Webb, P M Laskarzewski, C J Glueck.   

Abstract

The effects of nonphysician prescribed, self-obtained, self-administered exogenous anabolic-androgenic steroids and testosterone on plasma total, high- and low-density lipoprotein cholesterol (HDLC, LDLC), and triglycerides were evaluated in 14 adult white men, 11 body builders and 3 power weight lifters. Lipids and lipoprotein cholesterols were quantified during active physical conditioning, both on (for at least 1 month, mean +/- SD 1.8 months) and off (for at least 4 months, 7.3 +/- 2.7 months) self-administered exogenous androgenic steroids. The subjects took 50 to 100 mg methandrostenolone daily plus weekly injections of testosterone 100 to 200 mg and nandrolone decanoate 100 to 200 mg per week. Mean (SD) HDLC on exogenous androgenic steroids, 29 +/- 8 mg/dL, was severely depressed, and was less than 50% of the consistently elevated mean HDLC when exogenous steroids were not used (61 +/- 14 mg/dL, P less than .01 for paired differences). During anabolic steroid use, HDLC was less than or equal to the age- race- and sex-specific 10th percentile in 11 of the 14 men, whereas while off anabolic steroids, HDLC was greater than or equal to the 90th percentile in 7 of the 13 men, and in the top quartile for 3 of the remaining 6 men. Mean LDLC was higher on androgenic steroids (150 +/- 44) than off (125 +/- 38 mg/dL), P less than .05 for paired differences. The ratio of LDLC/HDLC during exogenous steroid use (6.0 +/- 3.7) was nearly triple the ratio obtained when steroids were not taken (2.2 +/- 1.0), P less than .01 for paired differences.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6493049     DOI: 10.1016/0026-0495(84)90222-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Misusing anabolic drugs.

Authors:  H M Perry; B N Littlepage
Journal:  BMJ       Date:  1992-11-21

Review 2.  Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes.

Authors:  M Alén; P Rahkila
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 3.  Epidemiological and policy issues in the measurement of the long term health effects of anabolic-androgenic steroids.

Authors:  C E Yesalis; J E Wright; M S Bahrke
Journal:  Sports Med       Date:  1989-09       Impact factor: 11.136

4.  Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone.

Authors:  S P Tam; T K Archer; R G Deeley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 5.  Effects of weight training on risk factors for coronary artery disease.

Authors:  B F Hurley; P F Kokkinos
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

Review 6.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 7.  Age-related changes in male gonadal function. Implications for therapy.

Authors:  D Maas; A Jochen; B Lalande
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 8.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 9.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

10.  Evaluation of vascular reactivity of young male hypogonadotrophic hypogonadism patients.

Authors:  Ferhat Deniz; Necip Ermiş; Alper Kepez; Bariş Türk; Murat Akkoyunlu; Batuhan Kara; Mustafa Kutlu
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-12       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.